Sign In
Buy NSPR
$0.96
-0.0499 (-4.94%)
At Close: Jun 03, 2026
UPDATE: InspireMD to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020 and Provide Corporate Update
08:05pm, Wednesday, 29'th Jul 2020
Conference Call to be held Wednesday, August 5, 2020 at 8:30am ETTEL AVIV, Israel, July 29, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Preve
InspireMD to Report Second Quarter 2020 Financial Results on Wednesday, August 5, 2020 and Provide Corporate Update
12:30pm, Tuesday, 28'th Jul 2020
Conference Call to be held Thursday, August 5, 2020 at 8:30am ETTEL AVIV, Israel, July 28, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Preven
InspireMD Gains Registration Clearance of its CGuard™ Embolic Prevention System (EPS) in Brazil
12:00pm, Thursday, 23'rd Jul 2020
TEL AVIV, Israel, July 23, 2020 (GLOBE NEWSWIRE) -- InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid
MICT Closes Acquisition of GFH with $15 Million in Committed Funding | Finance Magnates
09:05am, Thursday, 02'nd Jul 2020
MICT has completed the acquisition of a wholly-owned subsidiary of Global Fintech Holdings Ltd. for approximately $25 million in convertible securities.
InspireMD Announces Late-Breaking Presentation of Early SIBERIA Clinical Trial Results to be Featured in an e-Course at EuroPCR
02:00pm, Thursday, 25'th Jun 2020
TEL AVIV, Israel, June 25, 2020 -- InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by.
TORONTO, ONTARIO / ACCESSWIRE / June 18, 2020 / GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) ("GlobeX" or the "Company"), the leader in Swiss hosted cybersecurity and Internet privacy
InspireMD (NYSEAMERICAN:NSPR) Downgraded to “Hold” at Zacks Investment Research
07:48am, Wednesday, 17'th Jun 2020
Zacks Investment Research lowered shares of InspireMD (NYSEAMERICAN:NSPR) from a buy rating to a hold rating in a research report sent to investors on Tuesday, Zacks.com reports. According to Zacks, �
MICT, Inc. (MICT) Management on Q1 2020 Results - Earnings Call Transcript
06:52pm, Tuesday, 16'th Jun 2020
MICT, Inc. (NASDAQ:MICT) Q1 2020 Results Conference Call June 16, 2020 09:00 AM ET Company Participants Darren Mercer - Interim Chief Executive Officer Moran Am
TORONTO, ON / ACCESSWIRE / June 16, 2020 / GlobeX Data Ltd. (OTCQB:SWISF) (CSE:SWIS) ("GlobeX" or the "Company"), the leader in Swiss hosted cyber security and Internet privacy sol
Barstool Sports’ Dave Portnoy Is Leading an Army of Day Traders
05:51pm, Friday, 12'th Jun 2020
With sports canceled, Barstool Sports' Dave Portnoy started betting on the stock market instead.
Barstool Sports' Dave Portnoy is leading an army of day traders - BNN Bloomberg
05:20pm, Friday, 12'th Jun 2020
Barstool Sports’ Dave Portnoy had bought just one stock in his life before the quarantine hit. When the country shut down in March, canceling sports and sports betting, the founder of the brash, mis
Davey’s miraculous nano-cap trade
08:55am, Friday, 12'th Jun 2020
In March, as the coronavirus pandemic forced entire countries into lockdown, Dave Portnoy found himself with two things that often make for a troubling combination: a lot of money and a lot of time.
InspireMD Announces Publication of 12-Month Results of CGuard™ EPS PARADIGM Trial in EuroIntervention
12:00pm, Wednesday, 10'th Jun 2020
Results indicate that 12 months after carotid intervention the CGuard EPS MicroNET-covered stent delivers sustained protection against postprocedural neurologic events TEL.
Welcome Hyatt Hotels To Your Portfolio (NYSE:H)
04:18pm, Monday, 08'th Jun 2020
Hyatt Hotels, with its leading profitability, strong balance sheet, and undervalued stock, presents another excellent buying opportunity for investors willing t
InspireMD, Inc. (NYSE American: NSPR), the developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced today the closing, on Jun
